Search research articles
Contact Us
Filters
Showing results (31-40 of 64) with videos related to
Page
of 7
Sort By:
Anti-Cancer Drug Design
|
March 1, 1995
Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNA
B Plouvier, R Houssin, N Helbecque, et al.
Anti-Cancer Drug Design
|
February 1, 1992
Relationship between DNA-binding and biological activity of anilinoacridine derivatives containing the nucleic acid-binding unit SPKK
F Bailly, C Bailly, N Helbecque, et al.
Biochimica Et Biophysica Acta
|
May 8, 1990
Conformational study of the chromosomal protein MC1 from the archaebacterium Methanosarcina barkeri
M Imbert, B Laine, N Helbecque, et al.
Biochemical and Biophysical Research Communications
|
April 29, 1988
DNA-binding and DNA-cleaving properties of a synthetic model AGAGLU related to the antitumour drugs AMSA and bleomycin
C Bailly, A Kenani, N Helbecque, et al.
Biochemical and Biophysical Research Communications
|
February 26, 1982
Purification by affinity chromatography of the solubilized oligosaccharyltransferase from hen oviducts using a privileged secondary structure adopting peptide
J P Aubert, M Chiroutre, J P Kerckaert, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
March 7, 2000
Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus
A Meirhaeghe, L Fajas, N Helbecque, et al.
Neurology
|
June 13, 2001
The angiotensin I converting enzyme gene as a susceptibility factor for dementia
F Richard, I Fromentin-David, F Ricolfi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 16, 2000
Intronic polymorphism in the fatty acid transport protein 1 gene is associated with increased plasma triglyceride levels in a French population
A Meirhaeghe, G Martin, M Nemoto, et al.
Journal of Inorganic Biochemistry
|
August 1, 1986
Molecular interaction between bleomycin and amsacrine in the presence of cupric ions
J L Bernier, A Kenani, R Houssin, et al.
Anti-Cancer Drug Design
|
August 1, 1987
Chelating, DNA-binding and DNA-cleaving properties of a synthetic model for bleomycin
A Kenani, M Lohez, R Houssin, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 64) with videos related to
Sort By:
Page
of 7
Anti-Cancer Drug Design
|
March 1, 1995
Influence of the methyl substituents of a thiazole-containing lexitropsin on the mode of binding to DNA
B Plouvier, R Houssin, N Helbecque, et al.
Anti-Cancer Drug Design
|
February 1, 1992
Relationship between DNA-binding and biological activity of anilinoacridine derivatives containing the nucleic acid-binding unit SPKK
F Bailly, C Bailly, N Helbecque, et al.
Biochimica Et Biophysica Acta
|
May 8, 1990
Conformational study of the chromosomal protein MC1 from the archaebacterium Methanosarcina barkeri
M Imbert, B Laine, N Helbecque, et al.
Biochemical and Biophysical Research Communications
|
April 29, 1988
DNA-binding and DNA-cleaving properties of a synthetic model AGAGLU related to the antitumour drugs AMSA and bleomycin
C Bailly, A Kenani, N Helbecque, et al.
Biochemical and Biophysical Research Communications
|
February 26, 1982
Purification by affinity chromatography of the solubilized oligosaccharyltransferase from hen oviducts using a privileged secondary structure adopting peptide
J P Aubert, M Chiroutre, J P Kerckaert, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
March 7, 2000
Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus
A Meirhaeghe, L Fajas, N Helbecque, et al.
Neurology
|
June 13, 2001
The angiotensin I converting enzyme gene as a susceptibility factor for dementia
F Richard, I Fromentin-David, F Ricolfi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
May 16, 2000
Intronic polymorphism in the fatty acid transport protein 1 gene is associated with increased plasma triglyceride levels in a French population
A Meirhaeghe, G Martin, M Nemoto, et al.
Journal of Inorganic Biochemistry
|
August 1, 1986
Molecular interaction between bleomycin and amsacrine in the presence of cupric ions
J L Bernier, A Kenani, R Houssin, et al.
Anti-Cancer Drug Design
|
August 1, 1987
Chelating, DNA-binding and DNA-cleaving properties of a synthetic model for bleomycin
A Kenani, M Lohez, R Houssin, et al.
Page
of 7